Rosa Lillo

417 total citations
21 papers, 338 citations indexed

About

Rosa Lillo is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Rosa Lillo has authored 21 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Rosa Lillo's work include T-cell and B-cell Immunology (9 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (4 papers). Rosa Lillo is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (4 papers). Rosa Lillo collaborates with scholars based in Spain, Switzerland and United States. Rosa Lillo's co-authors include F. García‐Sánchez, José L. Vicário, A. Balas, Luís Madero, Natalia Wright, Antonio Carúz, Teresa Laı́n de Lera, Joaquı́n Teixidó, Juan A. Bueren and José Luís Merino and has published in prestigious journals such as Blood, Molecular Therapy and British Journal of Haematology.

In The Last Decade

Rosa Lillo

20 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Lillo Spain 11 126 116 103 97 74 21 338
S Kyoizumi United States 8 174 1.4× 210 1.8× 74 0.7× 117 1.2× 82 1.1× 8 367
Béatrice Panterne France 9 79 0.6× 203 1.8× 79 0.8× 192 2.0× 52 0.7× 15 373
J Burgess United States 6 111 0.9× 252 2.2× 114 1.1× 54 0.6× 50 0.7× 8 340
K Sugita Japan 10 80 0.6× 224 1.9× 52 0.5× 142 1.5× 88 1.2× 22 448
Salomé Glauzy France 14 354 2.8× 115 1.0× 98 1.0× 83 0.9× 94 1.3× 16 522
V Duvert France 8 306 2.4× 184 1.6× 106 1.0× 78 0.8× 36 0.5× 8 465
SHOJIRO YANO Japan 11 98 0.8× 55 0.5× 77 0.7× 123 1.3× 37 0.5× 32 413
Angela Sullivan United Kingdom 7 90 0.7× 223 1.9× 166 1.6× 78 0.8× 55 0.7× 8 382
Anja Troeger Germany 12 170 1.3× 91 0.8× 106 1.0× 183 1.9× 47 0.6× 35 493
K Unverzagt United States 10 103 0.8× 315 2.7× 118 1.1× 67 0.7× 64 0.9× 14 395

Countries citing papers authored by Rosa Lillo

Since Specialization
Citations

This map shows the geographic impact of Rosa Lillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Lillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Lillo more than expected).

Fields of papers citing papers by Rosa Lillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Lillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Lillo. The network helps show where Rosa Lillo may publish in the future.

Co-authorship network of co-authors of Rosa Lillo

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Lillo. A scholar is included among the top collaborators of Rosa Lillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Lillo. Rosa Lillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burzotta, Francesco, Cristina Aurigemma, Gabriella Locorotondo, et al.. (2025). Evolution and long-term impact of concomitant valvulopathies in patients undergoing transcatheter aortic valve implantation. Minerva Cardiology and Angiology. 74(1). 135–145.
2.
Lillo, Rosa, Francesca Graziani, Giulia Iannaccone, et al.. (2022). Right ventricle systolic function and right ventricle-pulmonary artery coupling in patients with severe aortic stenosis and the early impact of TAVI. The International Journal of Cardiovascular Imaging. 38(8). 1761–1770. 10 indexed citations
3.
Cervera, Áurea, Rosa Lillo, F. García‐Sánchez, et al.. (2006). Flow cytometric assessment of hematopoietic cell subsets in cryopreserved preterm and term cord blood, influence of obstetrical parameters, and availability for transplantation. American Journal of Hematology. 81(6). 397–410. 11 indexed citations
4.
Garcı́a-Castro, Javier, Jesús Martínez‐Palacio, Rosa Lillo, et al.. (2005). Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors. Cancer Gene Therapy. 12(4). 341–349. 50 indexed citations
5.
García‐Sánchez, F., et al.. (2005). Four new HLA class I alleles in Cauacasoids*. Tissue Antigens. 66(1). 51–53. 2 indexed citations
6.
Balas, A., et al.. (2004). Sequencing of two new HLA class II alleles: DRB3*0218 and DQB1*030202. Tissue Antigens. 63(6). 614–616. 5 indexed citations
7.
Garcı́a-Castro, Javier, Paula Rı́o, Rosa Lillo, et al.. (2003). Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model. Gene Therapy. 10(16). 1328–1335. 7 indexed citations
8.
Wright, Natalia, Teresa Laı́n de Lera, Rosa Lillo, et al.. (2003). Transforming growth factor-β1 down-regulates expression of chemokine stromal cell–derived factor-1: functional consequences in cell migration and adhesion. Blood. 102(6). 1978–1984. 78 indexed citations
9.
Balas, A., et al.. (2002). Elongation of the cytoplasmic domain, due to a point deletion at exon 7, results in an HLA‐C null allele, Cw*0409 N. Tissue Antigens. 59(2). 95–100. 19 indexed citations
10.
Garcı́a-Castro, Javier, José C. Segovia, F. García‐Sánchez, et al.. (2001). Selective Transduction of Murine Myelomonocytic Leukemia Cells (WEHI-3B) with Regular and RGD-Adenoviral Vectors. Molecular Therapy. 3(1). 70–77. 15 indexed citations
12.
Balas, A., et al.. (1999). Complete cDNA coding sequence of a new HLA-A3 subtype (A*0304) with a new HLA polymorphism at exon 3. Immunogenetics. 49(4). 360–361. 2 indexed citations
13.
Díaz, Miguel Ángel, et al.. (1999). Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.. PubMed. 84(1). 32–5. 41 indexed citations
15.
Balas, A., et al.. (1998). Characterization and distribution of HLA‐B*5002 in a Spanish population sample. Tissue Antigens. 52(2). 183–186. 9 indexed citations
16.
Balas, A., et al.. (1998). Complete coding sequence of a serologically undefined HLA-B antigen: HLA-B * 1537. Immunogenetics. 47(6). 501–502. 7 indexed citations
17.
Madero, Luís, Miguel Ángel Díaz, A. Balas, et al.. (1998). Progenitor cell subsets and engraftment kinetics in children undergoing autologous peripheral blood stem cell transplantation. British Journal of Haematology. 101(1). 104–110. 26 indexed citations
18.
Balas, A., et al.. (1998). Complete coding sequence of HLA‐B*2712: a serologic B27‐negative antigen associated to Bw6. Tissue Antigens. 51(4). 394–397. 23 indexed citations
19.
Balas, A., et al.. (1998). Characterization of a new HLA‐B18 allele, B*1806, which lacks expression of the Bw6 epitope. Tissue Antigens. 52(6). 579–582. 10 indexed citations
20.
Balas, A., et al.. (1997). HLA‐B14 subtyping by semi‐nested PCR‐SSP and haplotype distribution in a Spanish population. Tissue Antigens. 50(6). 671–674. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026